Børtind Invest completed the acquisition of a 90% stake in Medibrix from Fürst Medisinsk Laboratorium.

Synopsis

Børtind Invest, an investment company, completed the acquisition of a 90% stake in Medibrix, a healthcare software company, from Fürst Medisinsk Laboratorium, a private medical laboratory in Norway. Financial terms were not disclosed.

Principals

target

Medibrix (formerly Helseboka)

bidder

Bortind Invest As

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

schjodt

HQ - Oslo, Norway

legal advisors

vendor

389

Deals

£ 68.03 B

Total Value